The Cooper Companies, Inc.  

(Public, NYSE:COO)   Watch this stock  
Find more results for CAROL ROSENBERG�
130.53
+1.23 (0.95%)
Apr 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 128.81 - 130.95
52 week 105.35 - 145.34
Open 130.07
Vol / Avg. 381,106.00/486,639.00
Mkt cap 6.25B
P/E 22.05
Div/yield 0.03/0.05
EPS 5.92
Shares 47.86M
Beta 0.33
Inst. own 100%
Jun 2, 2014
Q2 2014 The Cooper Companies, Inc. Earnings Release (Estimated) Add to calendar
Mar 17, 2014
The Cooper Companies, Inc. Annual Shareholder Meeting
Mar 11, 2014
The Cooper Companies, Inc. at Barclays Healthcare Conference
Mar 6, 2014
Q1 2014 The Cooper Companies, Inc. Earnings Conference Call - Webcast
Mar 6, 2014
Q1 2014 The Cooper Companies, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '14) 2013
Net profit margin 17.84% 18.70%
Operating margin 20.15% 19.27%
EBITD margin - 28.49%
Return on average assets 9.27% 9.77%
Return on average equity 11.91% 12.88%
Employees 8,000 -
CDP Score - -

Address

Suite 590, 6140 Stoneridge Mall Road
PLEASANTON, CA 94588
United States - Map
+1-925-4603600 (Phone)
+1-925-4603649 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units, CooperVision, Inc. and CooperSurgical, Inc. CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperVision develops, manufactures and markets a range of monthly, two-week and single-use contact lenses, featuring advanced materials and optics. CooperVision's products are designed to solve vision challenges such as astigmatism, presbyopia and ocular dryness with a collection of spherical, toric and multifocal contact lenses. CooperSurgical offers an array of products used in the care and treatment of women's health. The Company participates in the women's healthcare market through offering quality products, technologies and service to clinicians worldwide.

Officers and directors

A. Thomas Bender Independent Chairman of the Board
Age: 74
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert S. Weiss President, Chief Executive Officer, Non-Independent Director
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Allan E. Rubenstein M.D. Independent Vice Chairman of the Board, Lead Director
Age: 65
Bio & Compensation  - Reuters
Gregory W. Matz Chief Financial Officer, Chief Risk Officer, Vice President
Age: 54
Bio & Compensation  - Reuters
Paul L. Remmell President and Chief Executive Officer of CooperSurgical Inc.
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Daniel G. McBride Esq. Chief Operating Officer, Executive Vice President; President of CooperVision, Inc.
Age: 49
Bio & Compensation  - Reuters
Carol R. Kaufman Executive Vice President, Chief Administrative Officer, Secretary, Chief Governance Officer
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tina Maloney Principal Accounting Officer, Corporate Controller
Age: 51
Bio & Compensation  - Reuters
Albert G. White III Vice President, Chief Strategy Officer
Age: 44
Bio & Compensation  - Reuters
Randal L. Golden Esq. General Counsel
Age: 52
Bio & Compensation  - Reuters